GOBankingRates works with many financial advertisers to showcase their products and services to our audiences.
These brands compensate us to advertise their products in ads across our site.
This compensation may impact how and where products appear on this site.

Commitment to Our Readers
GOBankingRates' editorial team is committed to bringing you unbiased reviews and information.
you could read more about oureditorial guidelinesand our products and servicesreview methodology.
Keep reading to discover Kass perspective on how a second Trump presidency might influencehealthcare costs for the middle class.
Signed into law by President Obama in 2010, the ACA expanded healthcare coverage through subsidies and Medicaid expansion.
By contrast, the Biden administration has been strengthening the ACA by increasing subsidies and expanding coverage.
Biden supports a public option, which would provide agovernment-run insurance planas an alternative to private insurance.
It could also lead to reduced protections for those with pre-existing conditions.
This could lead to reduced coverage or higher out-of-pocket costs for the middle class.
However, despite these promises, significant changes to drug pricing were not implemented during Trumps term.
If Trump succeeds in reducing drug prices, then the middle class would experience lower costs.
More From GOBankingRates
Share This Article: